六月 2026
- Home
- ParaPRO
六月 2026的ParaPRO市场份额分析
For more than 35 years, healthcare providers have selectively used permethrin to eradicate the scabies mite—the same molecule that has resulted in widespread resistance in head lice.
ParaPRO(包含公司地区分支机构)
查看更多网站流量和参与度信息- parapro.com
ParaPRO收入截至 六月 2026为 5M - 10M
ParaPRO主要域名产生的收入
3 年中ParaPRO主要域名的收入
ParaPRO主要域名的收入
ParaPRO热门域名的总访问量
了解ParaPRO市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
ParaPRO热门域名的平均访问时长
分析ParaPRO参与度指标。
过去 3 个月的平均访问时长
子公司明细
ParaPRO热门域名的平均页面浏览量
了解ParaPRO如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
ParaPRO 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻ParaPRO, LLC. sells assets to Cipher Pharmaceuticals Inc. in the amount of $89.5M.MISSISSAUGA - Cipher Pharmaceuticals acquires global product rights for Natroba (Spinosad) and the U.S. commercial sales team from ParaPRO, in a deal valued at USD 89.5 million.
七月 29, 2024阅读更多
新闻ParaPRO, LLC. launches Thought Leader AI.ParaPRO, a specialty pharmaceutical company focused on innovative treatments for human ectoparasites, today announced that it will unveil Thought Leader AI – a pioneering medical education platform that enables healthcare practitioners to engage "live" with leading clinical experts on topics of public health – at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Anaheim, CA, October 7-11, 2022.
十月 7, 2022阅读更多
新闻ParaPRO, LLC. launched Natroba Topical Suspension on Jan 9th '19.ParaPRO, a specialty pharmaceutical company focused on innovative anti-parasitic treatments, today announced the availability of Natroba™ (spinosad) Topical Suspension, 0.9%, the first product (new drug application) for scabies to be approved by the U.S. Food and Drug Administration (FDA) in more than 30 years.
一月 8, 2019阅读更多
查看 ParaPRO 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
